Chris Winchester DPhil is CEO of Oxford PharmaGenesis, an award-winning, independent HealthScience communications consultancy with 500 employees in Europe, North America and Asia Pacific. The company helps its clients in pharmaceutical and biotech companies communicate the evidence behind new drugs and vaccines to healthcare professionals, payers and patients. Chris is a Co-founder of Open Pharma, a Director of Oxford Health Policy Forum CIC and an Associate Fellow of Green Templeton College, Oxford.
Working group membership(s):
Open access